A detailed history of Arcataur Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Arcataur Capital Management LLC holds 6,311 shares of ABT stock, worth $651,295. This represents 0.26% of its overall portfolio holdings.

Number of Shares
6,311
Previous 6,160 2.45%
Holding current value
$651,295
Previous $678 Million 5.79%
% of portfolio
0.26%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$109.52 - $120.96 $16,537 - $18,264
151 Added 2.45%
6,311 $717 Million
Q4 2023

Feb 07, 2024

SELL
$90.19 - $110.4 $55,466 - $67,896
-615 Reduced 9.08%
6,160 $678 Million
Q3 2023

Oct 18, 2023

SELL
$95.53 - $114.62 $8,502 - $10,201
-89 Reduced 1.3%
6,775 $656 Million
Q2 2023

Jul 26, 2023

BUY
$100.78 - $112.29 $691,753 - $770,758
6,864 New
6,864 $748 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $181B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Arcataur Capital Management LLC Portfolio

Follow Arcataur Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcataur Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arcataur Capital Management LLC with notifications on news.